Question

I am a breastfeeding mother and i want to know if it is safe to use Recombinant human TNF? Is Recombinant human TNF safe for nursing mother and child? Does Recombinant human TNF extracts into breast milk? Does Recombinant human TNF has any long term or short term side effects on infants? Can Recombinant human TNF influence milk supply or can Recombinant human TNF decrease milk supply in lactating mothers?

Recombinant human TNF lactation summary

Recombinant human TNF is safe in breastfeeding
  • DrLact safety Score for Recombinant human TNF is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of Recombinant human TNF is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that Recombinant human TNF does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of Recombinant human TNF safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Recombinant human TNF usage in lactation

Its higher molecular weight makes it secretion into breast milk unlikely. It is not absorbed by gastrointestinal tract due to its protein structure.

Answer by DrLact: About Recombinant human TNF usage in lactation

Recombinant human TNF is minimally excreted into breastmilk and poorly absorbed by the infant, which would be expected because of its high molecular weight of approximately 150,000. However, long-term follow-up data on infants breastfed during maternal Recombinant human TNF use are not available. The risk of adverse effects in older infants is not known, but thought to be unlikely.[1] Most experts feel that the drug is a low risk to the nursing infant and can be given during breastfeeding.[2][3][4][5][6][7]

Recombinant human TNF Side Effects in Breastfeeding

A woman with rheumatoid arthritis began Recombinant human TNF 25 mg subcutaneously twice a week at 3 months postpartum and later switched to a dose of 50 mg subcutaneously once a week. Her infant was breastfed (extent not stated) until 6 months of age. The infant was reportedly healthy at 3 years of age.[10] A case-control study of women with chronic arthritic conditions found 5 women who received Recombinant human TNF during pregnancy and lactation (extent not stated). No differences were observed in the 5 infants' growth parameters, developmental milestones, vaccinations and diseases in the first year of life compared to those not exposed to the drugs with lactation.[11]

Alternate Drugs

Auranofin(Low Risk)
Anakinra(Low Risk)
Abatacept(Low Risk)
Methotrexate(Low Risk)
Rituximab(Low Risk)
Leflunomide(Dangerous)
Penicillamine(Low Risk)
Tocilizumab(Low Risk)
Adapalene(Safe)
Secukinumab(Low Risk)
Erythromycin(Low Risk)
Hydroquinone(Low Risk)
Tazarotene(Low Risk)
Pimecrolimus(Low Risk)
Neomycin(Safe)
Ustekinumab(Low Risk)
Isotretinoin(Unsafe)
Docusate(Safe)
Cascara Sagrada(Low Risk)
Dimenhydrinate(Low Risk)
Droperidol(Low Risk)
Rifaximin(Safe)
Bisacodyl(Safe)
Ursodiol(Safe)
Cisapride(Safe)
Cimetidine(Low Risk)
Alosetron(Low Risk)
Senna(Safe)
Cyclizine(Low Risk)
Doxylamine(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.